Evaluation of human neutrophil gelatinase-associated lipocalin level in asthma-COPD overlap syndrome of elderly patients
Journal of Pulmonology and Intensive Care · 2023
DOI: 10.51271/jopic-0008 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Pulmonology and Intensive Care, 2023. Verfasst von Serap Duru und 1 weiteren Autor:innen.
Themen: COPD
Abstract (Originalsprache)
Aims
Human neutrophil gelatinase-associated lipocalin (NGAL) is a protein considered as a noninvasive prognostic biomarker in Asthma-COPD overlap syndrome (ACO). In this study we aimed to show the usability of NGAL as a biomarker in ACO characterized with airway inflammation in over 65 years old.
Methods
Three patient groups (Group I: COPD, n: 50, Group II: Asthma, n:50, Group III: ACO, n:50) and a healhty non smoker group (Group IV, n:50) are taken into study. The serum NGAL levels of groups are compared. In Group I, II, III the level of serum NGAL is compared with the age, duration of smoking (pocket/year), number of attack per year, respiratory function values, serum C reaktive protein (CRP, mg/dL), serum IgE (IU/mL) and blood neutrophil-to-lymphocyte rate and atopy.
Results
In patients having ACO when the maximum level of serum exist, it is observed that serum NGAL level is increased as the number of attacks is increased (p
Zitieren
APA
Duru, S., & Uçar, F. (2023). Evaluation of human neutrophil gelatinase-associated lipocalin level in asthma-COPD overlap syndrome of elderly patients. Journal of Pulmonology and Intensive Care. https://doi.org/10.51271/jopic-0008
Vancouver
Duru S, Uçar F. Evaluation of human neutrophil gelatinase-associated lipocalin level in asthma-COPD overlap syndrome of elderly patients. Journal of Pulmonology and Intensive Care. 2023. doi:10.51271/jopic-0008
BibTeX
@article{Duru2023,
author = {Duru, Serap and Uçar, Fatma},
title = {Evaluation of human neutrophil gelatinase-associated lipocalin level in asthma-COPD overlap syndrome of elderly patients},
journal = {Journal of Pulmonology and Intensive Care},
year = {2023},
doi = {10.51271/jopic-0008}
}
EUVIMED